Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content

Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content

US Patent 8258095 · Granted Sep 4, 2012

Estimated economic value: $7,827,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of ultrarapid acting insulin2025
Use of ultrarapid acting insulin2025
Use of ultrarapid acting insulin2025
Use of ultrarapid acting insulin2025
Method of treating diabetes type 2 by administering ultrarapid acting insulin2024
Method of treating diabetes type 2 by administering ultrarapid acting insulin2024
Use of ultrarapid acting insulin2024
Use of ultrarapid acting insulin2024
Use of ultrarapid acting insulin2023
Use of ultrarapid acting insulin2023
Use of ultrarapid acting insulin2023
Use of ultrarapid acting insulin2023